Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
6.23
-0.02 (-0.32%)
At close: Aug 7, 2026, 4:00 PM EDT
6.30
+0.07 (1.12%)
After-hours: Aug 7, 2026, 7:35 PM EDT
MRVI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 208.78 | 185.74 | 259.19 | 288.95 | 883 | 799.24 | |
Revenue Growth | -5.03% | -28.34% | -10.30% | -67.28% | 10.48% | 181.32% |
Cost of Revenue | 135.93 | 151.75 | 150.88 | 148.74 | 168.96 | 140.56 |
Gross Profit | 72.85 | 33.99 | 108.31 | 140.2 | 714.04 | 658.68 |
Selling, General & Admin | 128.14 | 145.12 | 161.77 | 151.39 | 129.26 | 100.06 |
Research & Development | 15.22 | 17.4 | 19.22 | 17.28 | 18.37 | 15.22 |
Other Operating Expenses | 46.5 | 86.74 | 162.93 | 3.18 | -7.8 | 11.25 |
Total Operating Expenses | 189.86 | 249.26 | 343.93 | 171.85 | 139.83 | 126.53 |
Operating Income | -41.03 | -215.27 | -235.62 | -31.65 | 574.22 | 554.65 |
Interest Income | 8.21 | 11.44 | 27.4 | 27.73 | 2.34 | - |
Interest Expense | -23.96 | -26.99 | -47.7 | -45.89 | -20.41 | -30.26 |
Other Non-Operating Income (Expense) | -0.66 | -4.15 | -5.57 | 667.55 | -4.67 | 6.38 |
Total Non-Operating Income (Expense) | -16.4 | -19.71 | -25.87 | 649.38 | -22.74 | -23.88 |
Pretax Income | -73.48 | -234.97 | -261.48 | 617.74 | 551.47 | 530.77 |
Provision for Income Taxes | -0.24 | -4.21 | -1.86 | 756.11 | 60.81 | 61.52 |
Net Income | -45.06 | -230.76 | -259.62 | -138.38 | 490.66 | 469.25 |
Minority Interest in Earnings | -19.5 | -99.99 | -114.78 | -19.35 | 270.46 | 287.21 |
Net Income to Common | -25.56 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Net Income Growth | - | - | - | - | 20.97% | 104.60% |
Shares Outstanding (Basic) | 146 | 144 | 138 | 132 | 255 | 258 |
Shares Outstanding (Diluted) | 146 | 144 | 138 | 132 | 255 | 258 |
Shares Change | 2.30% | 4.68% | 4.54% | -48.33% | -0.96% | - |
EPS (Basic) | -0.52 | -0.90 | -1.05 | -0.90 | 1.67 | 1.59 |
EPS (Diluted) | -0.52 | -0.90 | -1.05 | -0.90 | 1.67 | 1.56 |
EPS Growth | - | - | - | - | 7.05% | -33.90% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -35.11 | -69.99 | -15.05 | 73.54 | 519.99 | 353.72 |
Free Cash Flow Growth | - | - | - | -85.86% | 47.01% | 179.00% |
Free Cash Flow Per Share | -0.24 | -0.48 | -0.11 | 0.56 | 2.04 | 1.37 |
Gross Margin | 34.89% | 18.30% | 41.79% | 48.52% | 80.87% | 82.41% |
Operating Margin | -19.65% | -115.89% | -90.91% | -10.95% | 65.03% | 69.40% |
Profit Margin | -21.58% | -124.24% | -100.17% | -47.89% | 55.57% | 58.71% |
FCF Margin | -16.82% | -37.68% | -5.81% | 25.45% | 58.89% | 44.26% |
EBITDA | 15.53 | -154.79 | -178.75 | 17.13 | 612.32 | 588.19 |
EBITDA Margin | 7.44% | -83.34% | -68.97% | 5.93% | 69.35% | 73.59% |
EBIT | -41.03 | -215.27 | -235.62 | -31.65 | 574.22 | 554.65 |
EBIT Margin | -19.65% | -115.89% | -90.91% | -10.95% | 65.03% | 69.40% |
Effective Tax Rate | 0.32% | 1.79% | 0.71% | 122.40% | 11.03% | 11.59% |